Ritonavir-Boosted Protease Inhibitors but Not Cobicistat Appear Safe in HIV-Positive Patients Ingesting Dabigatran

Lignende værker

• Management of Antiretroviral Therapy with Boosted Protease Inhibitors—Darunavir/Ritonavir or Darunavir/Cobicistat
  af: Marin, Ruxandra-Cristina, et al.
  Udgivet: (2021)
• Effectiveness of Switching to Darunavir/Cobicistat in Virologically Suppressed HIV-Positive Patients Receiving Ritonavir-Boosted Protease Inhibitor–Based Regimen: The “STORE” Study
  af: Gori, Andrea, et al.
  Udgivet: (2020)
• Effects of ritonavir-boosted protease inhibitors on combined oral contraceptive pharmacokinetics and pharmacodynamics in HIV-positive women
  af: Barcellos, Teresa, et al.
  Udgivet: (2019)
• Effects of Etravirine Alone and with Ritonavir-Boosted Protease Inhibitors on the Pharmacokinetics of Dolutegravir
  af: Song, Ivy, et al.
  Udgivet: (2011)
• Is Ritonavir-Boosted Atazanavir a Risk for Cholelithiasis Compared to Other Protease Inhibitors?
  af: Hamada, Yohei, et al.
  Udgivet: (2013)